JPMorgan Chase & Co. Raises Position in Owens & Minor, Inc. (NYSE:OMI)

JPMorgan Chase & Co. boosted its holdings in shares of Owens & Minor, Inc. (NYSE:OMI) by 68.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 376,830 shares of the company’s stock after buying an additional 152,999 shares during the period. JPMorgan Chase & Co. owned approximately 0.49% of Owens & Minor worth $5,912,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in OMI. DekaBank Deutsche Girozentrale boosted its position in shares of Owens & Minor by 76.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock valued at $43,000 after acquiring an additional 1,356 shares during the last quarter. Quarry LP lifted its position in Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after purchasing an additional 1,561 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in Owens & Minor by 4.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company’s stock worth $491,000 after buying an additional 1,709 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock worth $44,000 after buying an additional 1,780 shares during the last quarter. Finally, Hsbc Holdings PLC increased its holdings in shares of Owens & Minor by 10.1% in the 2nd quarter. Hsbc Holdings PLC now owns 20,639 shares of the company’s stock worth $278,000 after buying an additional 1,885 shares during the last quarter. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the transaction, the chief financial officer now directly owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.62% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

OMI has been the subject of a number of research analyst reports. Barclays dropped their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. Citigroup cut their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a report on Tuesday, November 5th. Robert W. Baird reduced their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 5th. Finally, UBS Group dropped their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $18.50.

Owens & Minor Trading Down 3.0 %

NYSE OMI opened at $14.53 on Friday. The firm has a market cap of $1.12 billion, a PE ratio of -22.35, a price-to-earnings-growth ratio of 0.39 and a beta of 0.46. Owens & Minor, Inc. has a 1-year low of $11.42 and a 1-year high of $28.35. The stock has a 50-day moving average of $13.32 and a 200-day moving average of $14.20. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. The business’s revenue was up 5.0% on a year-over-year basis. As a group, sell-side analysts forecast that Owens & Minor, Inc. will post 1.49 EPS for the current year.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.